EE57 Recombinant Zoster Vaccine for High-Risk Ageing Adults in the Netherlands: Cost-Effectiveness and Value of Information Analyses
Dec 1, 2022, 00:00
10.1016/j.jval.2022.09.309
https://www.valueinhealthjournal.com/article/S1098-3015(22)02513-X/fulltext
Title :
EE57 Recombinant Zoster Vaccine for High-Risk Ageing Adults in the Netherlands: Cost-Effectiveness and Value of Information Analyses
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)02513-X&doi=10.1016/j.jval.2022.09.309
First page :
Section Title :
Open access? :
No
Section Order :
12117